Ashley K. Wiseman

Chromosome-specific retention of cancer-associated DNA hypermethylation following pharmacological inhibition of DNMT1

Peter A. Jones, Rochelle L. Tiedemann, Hui Shen, 2022, Communications Biology.

Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia

Peter A. Jones, Philip J. Chapman, P. Grandi, 2021, Nature Cancer.

DNA methylation dynamics and dysregulation delineated by high-throughput profiling in the mouse

Peter A. Jones, P. Laird, Hui Shen, 2022, bioRxiv.

UHRF1 ubiquitin ligase activity supports the maintenance of low-density CpG methylation

Rochelle L. Tiedemann, S. Baylin, S. Rothbart, 2024, bioRxiv.